Abstract
A synthetic pentasaccharide, containing an intact antithrombin III (ATIII) binding site that is in clinical studies a specific antifactor Xa agent, serves as a substrate for a heparin lyase (heparinase I, EC 4.2.2.7) from Flavobacterium heparinum. Heparinase I, currently being assessed as a heparin reversal agent, also reverses the antifactor Xa activity of this synthetic pentasaccharide by breaking it down to inactive disaccharide and trisaccharide products.
Original language | English |
---|---|
Pages (from-to) | 549-556 |
Number of pages | 8 |
Journal | Thrombosis Research |
Volume | 100 |
Issue number | 6 |
DOIs | |
State | Published - 15 Dec 2000 |
Externally published | Yes |
Keywords
- Heparin lyase
- Heparinase
- Neutralization
- Pentasaccharide
- Reversal